COVID-19 Seroprevalence Survey among Cancer Patients and Caregivers in Cancer Center
Not Applicable
- Conditions
- COVIDᆧCancer patientsCancer caregiverSeroprevalance
- Registration Number
- TCTR20201214005
- Lead Sponsor
- Thailand Science Research and Innovation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending (Not yet recruiting)
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
1. Cancer patients who received treatment at Chulabhorn Hospital
2. Cancer caregiver matched with cancer patients
Exclusion Criteria
Previous COVID-19 infection
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Seroprevalence of COVID-19 among cancer patient and cancer caregiver At the beginning of the study Immunoassay
- Secondary Outcome Measures
Name Time Method Correlation between seroprevalance of cancer patient and care giver At the beginning of the study Immunoassay